CTRI/2018/03/012742
Completed
Phase 1
Multimodal Imaging Biomarkers in monitoring the progression of Macular Telangiectasia.
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Giridhar Eye Institute
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients diagnosed with macular telangiectasia.
Exclusion Criteria
- •Other macular diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Not Applicable
Evaluation of optical coherence (OCT), imaging to examine the structure and form of coronary plaques following a heart attack.Coronary Artery DiseaseNon-ST elevation Myocardial InfarctionThrombolysed STEMIHigh risk Acute coronary syndromeCardiovascular - Coronary heart diseaseACTRN12615001234505niversity of Western Australia75
Withdrawn
Not Applicable
Image Biomarkers for Progression of AMDAMDNCT04537143Doheny Image Reading Center
Not yet recruiting
Not Applicable
An observational study on Macular Telangiectasia Type 2 characteristics using different imaging modalities in Indian populatioCTRI/2022/10/046686Aravind Eye Hospital Chennai
Terminated
Phase 4
Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaNCT00930345Assistance Publique - Hôpitaux de Paris33
Recruiting
Not Applicable
Analysis of imaging biomarkers in development and growth of geographic atrophy in Japanese with dry aged macular degeneratiodry age-related macular degenerationJPRN-UMIN000050605Jichi Medical University40